NASDAQ:MSLI (MSLI) (MSLI) Stock Price, News & Analysis → The World's First '$20 Trillion Drug?' (From Behind the Markets) (Ad) Free MSLI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$1.30▼$1.3050-Day Range N/A52-Week Range$0.70▼$1.33VolumeN/AAverage Volume56,140 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (MSLI) alerts: Email Address Ad Wall Street StarAI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About (MSLI) Stock (NASDAQ:MSLI)Merus Labs International Inc. is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. The Company's products include Elantan, Isoket, Deponit, Sintrom, Emselex/Enablex, Surgestone, Provames, Speciafoldine, Tredemine, Salagen, Estraderm MX and Vancocin. Elantan are tablets or capsules that belong to a group of medicines called organic nitrates. Isoket belongs to a group of medicines called organic nitrates. Deponit belongs to a group of medicines called nitrates. Sintrom is an anticoagulant indicated to treat and prevent thromboembolic diseases. Emselex/Enablex is used in adults to treat overactive bladder syndrome. Surgestone is used to treat women with menstrual irregularities due to ovulation disorder, dysmenorrhea and premenstrual syndrome. Provames is used as hormone replacement therapy in postmenopausal women with symptoms of estrogen deficiency.Read More Ad Wall Street StarAI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry MSLI Stock News HeadlinesJanuary 28, 2024 | msn.comMedico-Legal Society Of India Writes To PM Modi Raising Concerns Regarding Latest ICU GuidelinesJanuary 12, 2024 | msn.comHow did Lynn Yamada Davis die? Popular social media star and the face of Cooking with Lynja was 67April 25, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…January 12, 2024 | msn.comJohn Webb obituary: Former Brands Hatch circuit boss dies aged 92January 12, 2024 | msn.comBlackRock, world's largest asset manager, pays $12.5 bln for Global Infrastructure PartnersJanuary 4, 2024 | msn.comMan recovering after stabbing, suspect arrestedOctober 28, 2023 | msn.com'Inadequate Infrastructure Main Reason For Death Of Critical Patients' MSLI SurveyApril 12, 2023 | msn.comDisneyland announces closing date for Splash MountainApril 25, 2024 | DTI (Ad)How a $0.25 cent option contract makes my top traders feelIf you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…April 12, 2023 | msn.comGlastonbury resale dates confirmed with six tips to secure a ticketMarch 8, 2023 | msn.comKentucky man sentenced to 18 years for trafficking fentanyl into VirginiaMarch 8, 2023 | msn.comWake Up With Perfect Hair Every Morning and Extend Your Blowout When You Use Sleepy TieFebruary 23, 2023 | msn.com"You Ain't No Youngin": LeBron James Jokes With Damian Lillard About Getting Older In NBAFebruary 11, 2023 | msn.comNDMA dispatches 16.5 tons relief shipment to TurkiyeFebruary 11, 2023 | msn.comNew-look Blues look to get back on track, host CoyotesJanuary 15, 2023 | msn.comAs possible recession looms, these fields have best job security: reportDecember 29, 2022 | msn.comMohammed Ben Sulayem opens up on the ‘complexity’ of FIA presidential roleDecember 29, 2022 | msn.comBoston high school basketball player punches ref in face: PoliceNovember 21, 2022 | msn.comMangaluru autorickshaw blast ‘inspired by global terror groups’: PoliceMay 9, 2022 | wsj.comPulitzer Board Commends Journalists of Ukraine for War CoverageSee More Headlines Receive MSLI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (MSLI) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/10/2015Today4/25/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:MSLI CUSIPN/A CIK1031516 Webwww.meruslabs.com Phone+1-905-7260995FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMichael S. CloutierIndependent Chairman of the BoardBio & Compensation - Barry FishmanChief Executive Officer, DirectorBio & Compensation - Michael Scott BumbyChief Financial OfficerRobert McLayVice President - Sales and MarketingBio & Compensation - Frank RotmannVice President and Head of European OperationsBio & Compensation - Robert Bloch M.D.DirectorBio & Compensation - Theresa Sheila FirestoneIndependent DirectorBio & Compensation - David D. Guebert CPAIndependent DirectorBio & Compensation - Robert S. PollockIndependent DirectorBio & Compensation - Timothy G. SorensenIndependent DirectorBio & Compensation - More Executives MSLI Stock Analysis - Frequently Asked Questions How were (MSLI)'s earnings last quarter? (MSLI) (NASDAQ:MSLI) released its quarterly earnings data on Monday, August, 10th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.02 by $0.03. The company had revenue of $7.73 million for the quarter, compared to analysts' expectations of $17.19 million. What other stocks do shareholders of (MSLI) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (MSLI) investors own include ProMetic Life Sciences (PLI), Palatin Technologies (PTN), Anavex Life Sciences (AVXL), Biocept (BIOC), Cancer Genetics (CGIX), InterCloud Systems (ICLD), Merus Labs International (MSL), AllianceBernstein (AB) and Acorn Energy (ACFN). This page (NASDAQ:MSLI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (MSLI) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
